head_banner

Nūhou

SEATTLE–(BUSINESS WIRE)–E like me ka ʻikepili mai Coherent Market Insights, ka waiwai o ka honua.lako hanai enteralUa manaʻo ʻia ka mākeke ma 2020 he $ 3.26 biliona, i manaʻo ʻia i ka wā wānana (2020-2027).
ʻO nā hiʻohiʻona nui i ka mākeke ka piʻi ʻana o ka maʻi maʻi maʻi a me ka hoʻoweliweli e like me ka maʻi diabetes, ka maʻi kanesa, a me nā maʻi cardiovascular, ka piʻi ʻana o ka hoʻokuʻu ʻana o nā huahana hou, a me ka piʻi ʻana o ka hui pū ʻana a me ka loaʻa ʻana o nā mea pāʻani nui. Manaʻo ʻia kēia e kōkua i ka ulu ʻana o ka mākeke.
Wahi a kahi hōʻike i hoʻokuʻu ʻia e ka International Diabetes Federation (IDF) i Pepeluali 2020, ma kahi o 463 miliona mau mākua (20-79 mau makahiki) ma ka honua holoʻokoʻa i loaʻa i ka maʻi diabetes i 2019, a ua manaʻo ʻia e piʻi aʻe i 700 miliona ma ka honua holoʻokoʻa e 2045. Eia kekahi, e like me ke kumu hoʻokahi, ua make ka maʻi diabetes i ka 4.2 miliona mau make ma ka honua holoʻokoʻa i 2019, a ʻo 79% o nā pākeke me ka maʻi diabetes e noho ana ma nā ʻāina haʻahaʻa a me waena.
Eia kekahi, ua manaʻo ʻia i ka wā wānana, ʻoi aku ka nui o nā huahana hou e alakaʻi i ka ulu mākeke. No ka laʻana, i Iune 2020, ua hoʻokumu ʻo Applied Medical Technology, Inc. (AMT), kahi hui hana no nā lako hānai enteral a me nā huahana ʻokiʻoki, i kāna noi kelepona hou, AMT ONE Source.
Eia kekahi, ʻo nā mea pāʻani nui e hana ana i ka mākeke meaʻai meaʻai enteral honua e kālele ana i ka hoʻohana ʻana i nā hoʻolālā ulu inorganic e like me ka loaʻa ʻana a me ka hui pū ʻana e hoʻonui i kā lākou mākeke i ka mākeke honua. No ka laʻana, i Iulai 2017, ua hoʻopau ka hui lāʻau lapaʻau Cardinal Health, Inc. i ka loaʻa ʻana o ka mālama maʻi o Medtronic, thrombosis vein hohonu a me nā ʻoihana undernutrition no US $ 6.1 biliona, me ka nui o nā ʻoihana alakaʻi e like me Curity a me Kendall. , Dover, Argyle a me Kangaroo-kokoke kēlā me kēia haukapila ʻAmelika e hoʻohana i kēia mau hōʻailona.
ʻO ka nui o ka ulu ʻana o ka mākeke meaʻai enteral honua i ka wā wānana e manaʻo ʻia he 5.8%. ʻO kēia ma muli o ka piʻi ʻana o ka maʻi cardiovascular. No ka laʻana, e like me ka hōʻike o ka World Health Organization i ka makahiki 2017, ua manaʻo ʻia he 17.9 miliona mau kānaka i make i ka maʻi cardiovascular (CVD) i ka makahiki 2016, ʻo ia ka 31% o ka nui o ka make honua, a ma kahi o 85% o ka make ma muli o ka maʻi puʻuwai. a hahau.
Ma waena o nā ʻano huahana, e noho ka ʻāpana ʻai meaʻai i ka māhele mākeke nui loa i ka makahiki 2020 ma muli o ka hoʻonui ʻana o ka nui o nā ʻōnaehana nerve waena a me nā maʻi noʻonoʻo, ka mea i manaʻo ʻia e hoʻonui i ka noi no ka hānai ʻana. Wahi a kahi noiʻi 2019 i hoʻopuka hou ʻia, ʻo nā maʻi neurological ka lua o ke kumu nui o ka make ma kahi o 9 miliona mau kānaka a puni ka honua.
ʻO nā mea pāʻani nui e hana ana i ka mākeke meaʻai meaʻai enteral honua ʻo Cook Group, Abbott Laboratories, Cardinal Health, Inc., Boston Scientific Corporation, CONMED Corporation, Amsino International Inc., Applied Medical Technology, Inc., Becton, Dickinson and Company, B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Moog, Inc., Vygon SA, Dynarex Corporation a me Medela AG.
ʻO Coherent Market Insights kahi hui ʻike mākeke honua a me ka hui kūkākūkā e kālele ana i ke kōkua ʻana i ka nui o kā mākou mea kūʻai aku e hoʻokō i ka ulu hoʻololi ʻana ma ke kōkua ʻana iā lākou e hana i nā hoʻoholo ʻoihana koʻikoʻi. Loaʻa i kā mākou mea kūʻai aku nā poʻe komo mai nā ʻoihana ʻoihana like ʻole ma mua o 57 mau ʻāina a puni ka honua.
Ma muli o ka hoʻonui ʻia ʻana o ka ʻōnaehana nūnū waena a me nā maʻi olakino noʻonoʻo, kapaipu hānaiE noho ka māhele i ka māhele mākeke nui loa ma 2020.

Contact us for any demand of enteral feeding equipment or feeding tube by e-mail:middle@kelly-med.com /whatsAapp :0086-18810234748.


Ka manawa hoʻouna: ʻAukake-15-2021